leadf
logo-loader
viewBioSig Technologies, Inc.
(
NASDAQ:BSGM
)

BioSig Technologies forms three new evaluation agreements for its PURE EP System

BioSig Technologies, Inc. (NASDAQ:BSGM) CEO Kenneth Londoner tells Proctive the Westport, Connecticut-based group has formed three new evaluation agreements for the PURE EP System, its novel electrophysiology (EP) signal acquisition and analysis technology.

Londoner says new clinical sites due to receive BioSig’s PURE EP System include New York-Presbyterian/Weill Cornell Medical Center, Michigan Medicine–University Hospital, and Houston Methodist Hospital. New installations of the PURE EP System will now follow a shorter assessment cycle of 90 days based on favorable data from installation evaluations in 2020.

Quick facts: BioSig Technologies, Inc.

Follow
NASDAQ:BSGM

Price: 3 USD

Market Cap: $104.77 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

BioSig Technologies taps medical-device industry executive James Barry as...

BioSig Technologies Inc CEO Kenneth Londoner tells Proactive the group has appointed Dr James Barry as an independent board director. Londoner says Dr Barry has more than 30 years of experience in the medical device industry as an executive and corporate board director. He spent the majority...

2 days, 3 hours ago

2 min read